- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
AKR1C1/2 Polyclonal Antibody / Aldo-Keto Reductase 1C1/2 Antibody recognizes AKR1C1 and AKR1C2, two closely related members of the aldo-keto reductase superfamily. These cytoplasmic oxidoreductases participate in the metabolism of steroid hormones, prostaglandins, and other endogenous carbonyl-containing compounds. Both enzymes use NADPH as a preferred reducing cofactor and catalyze reactions involving ketone and hydroxyl groups. Their substantial sequence similarity results in overlapping substrate preferences, although differences in catalytic efficiency and substrate orientation contribute to distinct physiological activities.
AKR1C1 is commonly associated with 20-alpha hydroxysteroid dehydrogenase activity and participates in progesterone metabolism. By reducing the 20-keto group of progesterone, AKR1C1 can generate metabolites with diminished progestational activity. The enzyme also acts on additional steroid substrates and contributes to the regulation of local steroid availability. Its activity is particularly relevant to tissues in which steroid concentrations and receptor signaling are influenced by intracellular metabolism rather than circulating hormone levels alone.
AKR1C2 exhibits prominent 3-alpha hydroxysteroid dehydrogenase activity and participates in androgen metabolism. One important reaction involves the conversion of dihydrotestosterone to 3-alpha androstanediol, a metabolite with substantially reduced androgen receptor activity. Through this pathway, AKR1C2 can influence the local availability of potent androgens. Both enzymes also contribute to the metabolism of other steroid intermediates, reflecting their broader roles in maintaining steroid homeostasis.
Beyond steroid metabolism, AKR1C enzymes participate in cellular responses to reactive carbonyl compounds and oxidative stress. Their ability to reduce selected aldehydes and ketones connects these proteins to detoxification processes and metabolic adaptation. Changes in AKR1C expression have been investigated in hormone-responsive malignancies and other pathological conditions involving altered steroid signaling or redox balance. However, the biological consequences of increased or decreased expression depend on the specific enzyme, substrate environment, and cellular context.
Because AKR1C1 and AKR1C2 share extensive sequence identity and similar molecular weights, distinguishing their individual contributions can require isoform-selective reagents or complementary molecular approaches. AKR1C1/2 Polyclonal Antibody provides a means of examining these related enzymes collectively in studies of steroid metabolism, cellular oxidoreductase activity, and the regulation of local hormone availability.
Explore our Metabolism Antibodies for additional targets involved in steroid hormone metabolism, cellular oxidoreductase activity, and the regulation of metabolic pathways.
Differences in protocols and secondary/substrate sensitivity may require the AKR1C1/2 Polyclonal Antibody / Aldo-Keto Reductase 1C1/2 Antibody to be titrated for optimal performance.
Amino acids M1-K123 from human AKR1C1 were used as the immunogen for the AKR1C1/2 Polyclonal Antibody.
After reconstitution, the AKR1C1/2 Polyclonal Antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
AKR1C1 antibody, AKR1C2 antibody, aldo-keto reductase family 1 member C1 antibody, aldo-keto reductase family 1 member C2 antibody, 20-alpha hydroxysteroid dehydrogenase antibody, 3-alpha hydroxysteroid dehydrogenase antibody, dihydrodiol dehydrogenase antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.